Telangana Emerges as a Global Life Sciences Hub with over Rs. 36,000 Cr in Investments, Creating 51,000 Jobs

In a remarkable testament to Telangana’s growing prominence on the world stage, the state government announced unprecedented progress in the life sciences sector, securing over Rs. 36,000 crores in investments from over 140 projects over the last year. These investments are set to create 51,000 direct jobs and an estimated 1,50,000 indirect jobs, solidifying Telangana's status as a powerhouse in the global life sciences industry.

Speaking on the state’s achievements, Hon’ble Minister for Industries and Commerce, Shri Duddilla Sridhar Babu, highlighted that Telangana has become a focal point for both international and domestic life sciences companies, with Hyderabad serving as the epicenter for innovation. The minister attributed this rapid growth to the proactive, business-friendly policies championed by the Hon’ble Chief Minister and the government’s strategic focus on life sciences and healthcare.

Shri Duddilla Sridhar Babu Minister of Industries and Commerce, Government of Telangana said, “We have witnessed a surge of investments from several international and domestic companies, who have chosen Telangana as their gateway to India's rapidly growing life sciences ecosystem. From pharmaceutical manufacturing and R&D centers to GCC innovation hubs, these investments across the life sciences value chain make Telangana an undisputed leader in this space globally. This momentum not only includes significant investments from new entrants but also additional investments by companies that have already seen the value in expanding in Telangana. This is a strong indicator of their trust in present Government’s business friendly approach that we have championed over the last one year and the strong ecosystem built over the last 2-3 decades.”

He further added, that at the heart of Government strategy lies Genome Valley, India’s first and largest organized R&D cluster, which continues to attract industry leaders and pioneering research organizations.  Another area that the Government is excited about is the intersection of life sciences and technology. Hyderabad offers a deep talent pool with expertise in pharmaceuticals, biotechnology, AI / ML, data analytics, and digital

health. With these extraordinary strengths, Hyderabad has created a niche for itself, as the hotspot for lifesciences and healthcare Global Capability Centers (GCCs).

“We are proud that these investments highlight our ability to attract companies across the lifesciences and healthcare value chain that include pharma, biotech, medtech, healthcare providers and health insurance players. This is a result of our efforts to proactively reach-out to these global companies aggressively showcasing Hyderabad as a preferred destination.

We are also happy to share that we will shortly introduce a dedicated life sciences policy, which will further streamline processes, attract  investments, foster innovation, and drive sustainable growth across this critical sector.” he said while addressing the media.

This upcoming policy is designed to address the evolving needs of the life sciences industry, ensuring Telangana consolidates its position as an important node in the global life sciences value chain.

The past year has seen notable investments / expansions in and around Genome Valley like:

    European company KrKA and Laurus Labs announced a joint investment of Rs. 2000 Crores in Genome Valley to establish pharmaceutical finished products and biopharmaceutical manufacturing in the cluster. Additionally, Laurus inaugurated a  State-of-the-Art R&D center with an Rs. 250 Crores. Both these investments have a combined employment potential of 2800 people.

    Japanese pharmaceutical major Takeda announced a partnership with Biological E to manufacture 5 Crore Dengue vaccine doses annually from Genome Valley. With this investment, Hyderabad will lead the global fight back against dengue, further cementing our position as the vaccine capital of the world.

    Rx  Propellant  and  Terminus  Group’s  Rs.  2000  crore  investment  in Genome Valley will create world class lab space infrastructure to the extent of 20 Lakh sft to support innovation and R&D, which has potential to create 10,000 new jobs across multiple functions

    Government and Thermofisher has partnered together to establish the country’s first scale-up biological manufacturing facility and bioprocess design center in Genome Valley.

     Germany based Milteyni Biotec is setting up a world-class Cell and Gene

Therapy facility in Genome Valley.

     Aragen – One of India’s leading CRO/CDMO announced a Rs. 2000

Crore expansion plan in Nacharam thereby doubling down on their strengths in Telangana and creating 1000 new jobs.

     Several other including Switzerland based Ferring Pharma, Germany based DFE Pharma, USA based

Vivint Pharma, etc. are expanding in Genome Valley.

The state has seen massive success in attracting some of the most renowned global life sciences companies to Hyderabad. To highlight a few of the Global Capability and Innovation Centers that have been announced over the last one year:

    World’s leading biotechnology company – Amgen is establishing an innovation center, which is one of their largest centers worldwide, in Hyderabad. This center can accommodate 3000 people and the company has very aggressive expansion plans.

    Zoetis, the world’s largest animal health company inaugurated the technology and innovation center

    One of the world’s leading medical technology companies, Olympus headquartered in Japan, is establishing their engineering and R&D center in Hyderabad with about 500 people.

    America’s largest healthcare systems provider HCA Healthcare joins this illustrious list of organisations choosing to set -up their capability center here. They are establishing a large campus in the city.

    One of the world’s largest health services providers and a Fortune 16 company, Cigna, through its subsidiary Evernorth Health Services is setting-up a massive campus here in the city.

    Several others including ModMed of Canada, Rx Benefits of USA, etc are establishing their centers here.

    In addition to the above new investments, Minister Sridhar Babu mentioned that he was happy that the existing partners continue to further invest and scale their presence in Hyderabad.

    Medtronic’s first IT center outside of USA, here in the city, with an investment of about Rs. 500 Crores.

Companies like Sanofi, BMS, Providence, etc. are further expanding their already significant presence in Hyderabad.